BioNTech SE (BNTX) Reports Q2 EPS of EUR6.45

BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of EUR6.45. Revenue for the quarter came in at EUR3.2 billion.

The company reiterated BioNTech COVID-19 2022 vaccine revenue guidance of €13 billion to €17 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• Signet shares jump on Q2 profit beat, raised annual guidance
• BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts